
Extended-spectrum beta-lactamase orthopedic wound infections in Nigeria
Author(s) -
Olusolabomi J Idowu,
Anthony Onipede,
Ayodele Elkanah Orimolade,
Lawrence A. Akinyoola,
G. O. Babalola
Publication year - 2011
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/0974-777x.83524
Subject(s) - providencia , microbiology and biotechnology , colistin , enterobacter , medicine , serratia , cephalosporin , citrobacter freundii , gentamicin , citrobacter , nitrofurantoin , proteus , aztreonam , acinetobacter , enterobacteriaceae , antibiotics , antibiotic resistance , biology , bacteria , imipenem , escherichia coli , pseudomonas , biochemistry , genetics , gene
Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria are emerging and impacting significantly on the management of patients and hospital costs. Besides, they are not being routinely sought after in diagnostic laboratories thus contributing to treatment failure.